These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34362785)

  • 21. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
    Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
    Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.
    Niewczas MA; Mathew AV; Croall S; Byun J; Major M; Sabisetti VS; Smiles A; Bonventre JV; Pennathur S; Krolewski AS
    Diabetes Care; 2017 Mar; 40(3):383-390. PubMed ID: 28087576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD.
    Wan EYF; Yu EYT; Chan L; Mok AHY; Wang Y; Chan EWY; Wong ICK; Lam CLK
    Clin J Am Soc Nephrol; 2021 Jun; 16(6):898-907. PubMed ID: 33910887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Discovery to Translation: Characterization of C-Mannosyltryptophan and Pseudouridine as Markers of Kidney Function.
    Sekula P; Dettmer K; Vogl FC; Gronwald W; Ellmann L; Mohney RP; Eckardt KU; Suhre K; Kastenmüller G; Oefner PJ; Köttgen A
    Sci Rep; 2017 Dec; 7(1):17400. PubMed ID: 29234020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-Varying Association of Individual BP Components with eGFR in Late-Stage CKD.
    Sood MM; Akbari A; Manuel D; Ruzicka M; Hiremath S; Zimmerman D; McCormick B; Taljaard M
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):904-911. PubMed ID: 28356338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ;
    J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study.
    Wen D; Zheng Z; Surapaneni A; Yu B; Zhou L; Zhou W; Xie D; Shou H; Avila-Pacheco J; Kalim S; He J; Hsu CY; Parsa A; Rao P; Sondheimer J; Townsend R; Waikar SS; Rebholz CM; Denburg MR; Kimmel PL; Vasan RS; Clish CB; Coresh J; Feldman HI; Grams ME; Rhee EP;
    JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of GSTM1 Deletion With Progression of CKD in Children: Findings From the Chronic Kidney Disease in Children (CKiD) Study.
    Levy RV; Reidy KJ; Le TH; David V; Winkler C; Xu Y; Warady B; Furth S; Kaskel F; Melamed ML
    Am J Kidney Dis; 2022 Jul; 80(1):79-86. PubMed ID: 34871703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Metabolomics study of metabolites associated with the glomerular filtration rate.
    Peng H; Liu X; Ieong CA; Tou T; Tsai T; Zhu H; Liu Z; Liu P
    BMC Nephrol; 2023 Apr; 24(1):105. PubMed ID: 37085754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
    Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
    Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease.
    He WJ; Li C; Huang Z; Geng S; Rao VS; Kelly TN; Hamm LL; Grams ME; Arking DE; Appel LJ; Rebholz CM;
    Clin J Am Soc Nephrol; 2022 Jul; 17(7):966-975. PubMed ID: 35777833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4.
    Xu H; Huang X; Arnlöv J; Cederholm T; Stenvinkel P; Lindholm B; Risérus U; Carrero JJ
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):690-7. PubMed ID: 24436478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population.
    Xiao W; Ye P; Wang F; Cao R; Bai Y; Wang X
    Kidney Blood Press Res; 2021; 46(5):541-549. PubMed ID: 34365457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arterial Stiffness and Chronic Kidney Disease Progression in Children.
    Azukaitis K; Kirchner M; Doyon A; Litwin M; Bayazit A; Duzova A; Canpolat N; Jankauskiene A; Shroff R; Melk A; Querfeld U; Schaefer F;
    Clin J Am Soc Nephrol; 2022 Oct; 17(10):1467-1476. PubMed ID: 36008353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents.
    Ng DK; Schwartz GJ; Warady BA; Furth SL; Muñoz A
    Am J Kidney Dis; 2017 Sep; 70(3):397-405. PubMed ID: 28549535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.